NUTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Nutex Health Inc (NUTX).


$172.30M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

NUTX Market Cap. (MRY)


NUTX Shares Outstanding (MRY)


NUTX Assets (MRY)


Total Assets

$655.32M

Total Liabilities

$453.43M

Total Investments

$0

NUTX Income (MRY)


Revenue

$479.95M

Net Income

$52.18M

Operating Expense

$65.64M

NUTX Cash Flow (MRY)


CF Operations

$23.15M

CF Investing

-$2.67M

CF Financing

$1.09M

NUTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

NUTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$655,320,393 (64.55%)

$398,245,497 (-7.76%)

$431,751,985 (9.40%)

$394,650,043 (232242.53%)

Assets Current

$292,478,885 (221.94%)

$90,848,403 (-7.27%)

$97,973,924 (-36.39%)

$154,015,179 (97963.86%)

Assets Non-Current

$362,841,508 (18.04%)

$307,397,094 (-7.90%)

$333,778,061 (38.71%)

$240,634,864 (1879713.01%)

Goodwill & Intangible Assets

$29,449,000 (-21.63%)

$37,578,899 (-1.63%)

$38,202,027 (1996.77%)

$1,821,946 (0%)

Shareholders Equity

$146,344,749 (138.14%)

$61,453,190 (-35.89%)

$95,862,701 (-16.39%)

$114,651,306 (10212.17%)

Property Plant & Equipment Net

$324,693,925 (20.53%)

$269,387,060 (-8.73%)

$295,152,608 (23.83%)

$238,356,833 (1923528.71%)

Cash & Equivalents

$43,581,412 (98.08%)

$22,002,056 (-35.77%)

$34,255,264 (-5.16%)

$36,118,284 (134014.16%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$2,849,814 (-15.95%)

$3,390,584 (-4.04%)

$3,533,285 (25.55%)

$2,814,178 (0%)

Trade & Non-Trade Receivables

$236,051,415 (276.02%)

$62,776,369 (7.65%)

$58,315,569 (-49.18%)

$114,759,434 (627583.83%)

Trade & Non-Trade Payables

$13,958,959 (-44.79%)

$25,281,393 (-8.17%)

$27,530,048 (55.95%)

$17,653,102 (2333.49%)

Accumulated Retained Earnings (Deficit)

-$356,893,371 (12.76%)

-$409,072,539 (-12.60%)

-$363,285,925 (-455.06%)

$102,315,623 (661.59%)

Tax Assets

$7,987,236 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$25,989,262 (405.06%)

$5,145,754 (-50.77%)

$10,452,211 (0%)

$0 (0%)

Total Debt

$340,296,690 (23.40%)

$275,756,948 (3.20%)

$267,201,513 (49.65%)

$178,551,505 (38473.20%)

Debt Current

$27,734,299 (38.14%)

$20,076,363 (-4.82%)

$21,092,108 (60.11%)

$13,173,431 (4110.24%)

Debt Non-Current

$312,562,391 (22.25%)

$255,680,585 (3.89%)

$246,109,405 (48.82%)

$165,378,074 (110152.05%)

Total Liabilities

$453,428,516 (42.08%)

$319,139,391 (2.48%)

$311,424,585 (53.36%)

$203,069,033 (15476.94%)

Liabilities Current

$140,866,125 (141.57%)

$58,313,052 (6.29%)

$54,862,969 (45.56%)

$37,690,959 (3167.10%)

Liabilities Non-Current

$312,562,391 (19.84%)

$260,826,339 (1.66%)

$256,561,616 (55.14%)

$165,378,074 (110152.05%)

NUTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$479,948,633 (93.80%)

$247,646,316 (12.93%)

$219,294,306 (-33.85%)

$331,531,311 (20.98%)

Cost of Revenue

$283,687,356 (33.27%)

$212,872,145 (3.42%)

$205,841,924 (35.20%)

$152,250,353 (30.77%)

Selling General & Administrative Expense

$41,923,972 (26.16%)

$33,229,718 (84.29%)

$18,030,832 (230.09%)

$5,462,344 (23.24%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$65,640,477 (-1.36%)

$66,547,919 (-84.16%)

$420,051,536 (4558.93%)

$9,016,060 (103.42%)

Interest Expense

$19,932,015 (22.15%)

$16,317,869 (30.64%)

$12,490,260 (101.59%)

$6,196,026 (-3.68%)

Income Tax Expense

$14,476,821 (385.70%)

-$5,067,084 (-138.71%)

$13,090,905 (1255.54%)

$965,731 (432.55%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$95,271,921 (319.40%)

-$43,423,715 (89.97%)

-$432,739,618 (-356.78%)

$168,525,285 (15.78%)

Net Income to Non-Controlling Interests

$43,092,753 (1723.72%)

$2,362,899 (129.69%)

-$7,959,172 (-122.15%)

$35,931,957 (-9.24%)

Net Income

$52,179,168 (213.96%)

-$45,786,614 (89.22%)

-$424,780,446 (-420.36%)

$132,593,328 (25.12%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$52,179,168 (213.96%)

-$45,786,614 (89.22%)

-$424,780,446 (-420.36%)

$132,593,328 (25.12%)

Weighted Average Shares

$5,437,003 (-99.19%)

$670,781,595 (3.23%)

$649,770,069 (1640.84%)

$37,325,057 (655.22%)

Weighted Average Shares Diluted

-

-

-

$37,325,057 (655.22%)

Earning Before Interest & Taxes (EBIT)

$86,588,004 (350.72%)

-$34,535,829 (91.35%)

-$399,199,281 (-385.64%)

$139,755,085 (24.13%)

Gross Profit

$196,261,277 (464.39%)

$34,774,171 (158.50%)

$13,452,382 (-92.50%)

$179,280,958 (13.75%)

Operating Income

$130,620,800 (511.10%)

-$31,773,748 (92.19%)

-$406,599,154 (-338.80%)

$170,264,898 (11.16%)

NUTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$2,665,222 (76.29%)

-$11,239,882 (-159.14%)

-$4,337,398 (88.27%)

-$36,975,444 (39.57%)

Net Cash Flow from Financing

$1,090,771 (148.06%)

-$2,269,778 (95.28%)

-$48,132,730 (61.75%)

-$125,853,033 (-1478.50%)

Net Cash Flow from Operations

$23,153,807 (1742.79%)

$1,256,452 (-97.52%)

$50,607,108 (-70.82%)

$173,432,486 (100.10%)

Net Cash Flow / Change in Cash & Cash Equivalents

$21,579,356 (276.11%)

-$12,253,208 (-557.71%)

-$1,863,020 (-117.57%)

$10,604,009 (-39.44%)

Net Cash Flow - Business Acquisitions and Disposals

-$361,325 (79.27%)

-$1,743,050 (-116.93%)

$10,295,016 (21173.46%)

-$48,853 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$2,303,897 (75.74%)

-$9,496,832 (35.10%)

-$14,632,414 (60.37%)

-$36,926,591 (39.65%)

Issuance (Repayment) of Debt Securities

-$7,400,122 (-379.59%)

$2,646,771 (147.34%)

-$5,591,013 (-71.04%)

-$3,268,883 (-107.96%)

Issuance (Purchase) of Equity Shares

$11,575,836 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$16,631,898 (486.46%)

$2,835,971 (1395.92%)

$189,581 (0%)

$0 (0%)

Depreciation Amortization & Accretion

$18,590,937 (4.90%)

$17,723,154 (34.31%)

$13,195,517 (70.04%)

$7,760,042 (30.28%)

NUTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

40.90% (192.14%)

14.00% (129.51%)

6.10% (-88.72%)

54.10% (-5.91%)

Profit Margin

10.90% (158.92%)

-18.50% (90.45%)

-193.70% (-584.25%)

40.00% (3.36%)

EBITDA Margin

21.90% (422.06%)

-6.80% (96.14%)

-176.00% (-495.51%)

44.50% (2.77%)

Return on Average Equity (ROAE)

62.80% (215.44%)

-54.40% (74.23%)

-211.10% (-228.17%)

164.70% (-96.48%)

Return on Average Assets (ROAA)

10.90% (203.81%)

-10.50% (88.75%)

-93.30% (-211.07%)

84.00% (-96.04%)

Return on Sales (ROS)

18.00% (229.50%)

-13.90% (92.36%)

-182.00% (-531.28%)

42.20% (2.68%)

Return on Invested Capital (ROIC)

13.90% (343.86%)

-5.70% (93.88%)

-93.10% (-185.73%)

108.60% (-97.10%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

3.09 (220.26%)

-2.57 (9.34%)

-2.84 (-115.14%)

18.73 (149.69%)

Price to Sales Ratio (P/S)

0.36 (-26.43%)

0.49 (-91.33%)

5.63 (1113.36%)

0.46 (1833.33%)

Price to Book Ratio (P/B)

1.18 (-40.10%)

1.97 (-84.74%)

12.88 (646.12%)

1.73 (127.54%)

Debt to Equity Ratio (D/E)

3.1 (-40.34%)

5.19 (59.83%)

3.25 (83.46%)

1.77 (254.00%)

Earnings Per Share (EPS)

10.25 (14742.86%)

-0.07 (89.55%)

-0.67 (-404.55%)

0.22 (22.22%)

Sales Per Share (SPS)

88.27 (23822.49%)

0.37 (9.50%)

0.34 (-96.21%)

8.88 (-83.98%)

Free Cash Flow Per Share (FCFPS)

3.83 (32058.33%)

-0.01 (-121.82%)

0.06 (-98.50%)

3.66 (-29.07%)

Book Value Per Share (BVPS)

26.92 (29156.52%)

0.09 (-37.84%)

0.15 (-95.18%)

3.07 (1441.48%)

Tangible Assets Book Value Per Share (TABVPS)

115.11 (21296.47%)

0.54 (-11.22%)

0.61 (-94.24%)

10.53 (30855.88%)

Enterprise Value Over EBIT (EV/EBIT)

5 (141.67%)

-12 (-200.00%)

-4 (-500.00%)

1 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

4.08 (116.25%)

-25.08 (-563.26%)

-3.78 (-386.01%)

1.32 (1873.13%)

Asset Turnover

1 (76.06%)

0.57 (17.84%)

0.48 (-77.06%)

2.1 (-96.17%)

Current Ratio

2.08 (33.25%)

1.56 (-12.77%)

1.79 (-56.29%)

4.09 (2904.41%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$20,849,910 (353.02%)

-$8,240,380 (-122.91%)

$35,974,694 (-73.65%)

$136,505,895 (435.67%)

Enterprise Value (EV)

$428,628,934 (1.66%)

$421,633,961 (-71.11%)

$1,459,485,817 (648.25%)

$195,054,216 (2361.68%)

Earnings Before Tax (EBT)

$66,655,989 (231.07%)

-$50,853,698 (87.65%)

-$411,689,541 (-408.25%)

$133,559,059 (25.82%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$105,178,941 (725.59%)

-$16,812,675 (95.64%)

-$386,003,764 (-361.67%)

$147,515,127 (24.44%)

Invested Capital

$781,720,546 (40.57%)

$556,108,438 (-2.72%)

$571,633,238 (14.88%)

$497,570,359 (90924.69%)

Working Capital

$151,612,760 (365.99%)

$32,535,351 (-24.53%)

$43,110,955 (-62.94%)

$116,324,220 (11772.15%)

Tangible Asset Value

$625,871,393 (73.53%)

$360,666,598 (-8.36%)

$393,549,958 (0.18%)

$392,828,097 (231169.89%)

Market Capitalization

$172,298,625 (42.70%)

$120,740,687 (-90.22%)

$1,234,563,131 (523.91%)

$197,874,054 (2685.03%)

Average Equity

$83,134,587 (-1.21%)

$84,153,715 (-58.18%)

$201,238,554 (149.89%)

$80,529,374 (3456.83%)

Average Assets

$480,124,026 (10.11%)

$436,052,454 (-4.24%)

$455,348,998 (188.55%)

$157,803,292 (3062.37%)

Invested Capital Average

$624,319,100 (3.25%)

$604,687,516 (41.07%)

$428,637,303 (233.19%)

$128,647,059 (4176.98%)

Shares

5,437,003 (-99.19%)

670,781,595 (3.23%)

649,770,069 (1252.91%)

48,027,683 (812.57%)